Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on July 26, 2024

MT Newswires

10 hours ago

Bernstein Adjusts Price Target on Vertex Pharmaceuticals to $502 From $458

Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks

10 hours ago

Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic

GuruFocus.com

a day ago

Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic

Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact

GuruFocus.com

a day ago

Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact

Is Vertex Pharmaceuticals' Monopoly in Danger?

Motley Fool

a day ago

Is Vertex Pharmaceuticals' Monopoly in Danger?

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Motley Fool

2 days ago

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...

GuruFocus.com

2 days ago

Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

Zacks

2 days ago

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Zacks

2 days ago

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Exploring Undervalued Stocks On US Exchanges With Discounts Ranging From 21.1% To 38.5%

Simply Wall St.

3 days ago

Exploring Undervalued Stocks On US Exchanges With Discounts Ranging From 21.1% To 38.5%

Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics

Pharmaceutical Technology

3 days ago

Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics

HHS gives thumbs down to bluebird’s fertility support programme

Pharmaceutical Technology

3 days ago

HHS gives thumbs down to bluebird’s fertility support programme

Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?

Zacks

3 days ago

Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?

MT Newswires

4 days ago

TD Cowen Adjusts Price Target on Vertex Pharmaceuticals to $500 From $450, Maintains Buy Rating

Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today

Zacks

4 days ago

Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today

MT Newswires

4 days ago

Cantor Fitzgerald Adjusts Price Target on Vertex Pharmaceuticals to $480 From $440

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street

Motley Fool

6 days ago

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street

3 Monster Stocks in the Making to Buy Right Now

Motley Fool

7 days ago

3 Monster Stocks in the Making to Buy Right Now

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

MT Newswires

7 days ago

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $566 From $500

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

7 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

MT Newswires

7 days ago

JPMorgan Raises Price Target on Vertex Pharmaceuticals to $505 From $450, Maintains Overweight Rating

MT Newswires

7 days ago

HC Wainwright Adjusts Vertex Pharmaceuticals' Price Target to $500 From $462

MT Newswires

10 days ago

Vertex Pharmaceuticals, Genomics Extend Drug Discovery, Development Collaboration by 3 Years

Vertex taps Orum to hunt for better ‘preconditioning’ drugs

BioPharma Dive

10 days ago

Vertex taps Orum to hunt for better ‘preconditioning’ drugs

MT Newswires

11 days ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $589 From $577, Maintains Buy Rating

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

11 days ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Zacks

11 days ago

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

MT Newswires

11 days ago

Vertex Files Lawsuit Against US Government to Pay for Fertility Treatment for Patients

MT Newswires

11 days ago

Vertex Pharmaceuticals Gets Health Canada Approval for Expanded Trikafta Use in Cystic Fibrosis Treatment

Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations

CNW Group

11 days ago

Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Motley Fool

12 days ago

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Motley Fool

12 days ago

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

Motley Fool

12 days ago

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever

Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

GuruFocus.com

14 days ago

Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

Motley Fool

15 days ago

1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

MT Newswires

15 days ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $455 From $402

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

16 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Zacks

17 days ago

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

MT Newswires

17 days ago

RBC Raises Price Target on Vertex Pharmaceuticals to $431 From $421, Keeps Sector Perform Rating

3 No-Brainer Stocks to Buy in July

Motley Fool

18 days ago

3 No-Brainer Stocks to Buy in July

Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).

Motley Fool

21 days ago

Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).

1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever

Motley Fool

21 days ago

1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever

Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

Motley Fool

22 days ago

Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Motley Fool

23 days ago

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA

Zacks

23 days ago

Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA

MT Newswires

24 days ago

FDA Accepts Vertex Pharmaceuticals' New-Drug Application for Combination Therapy to Treat Cystic Fibrosis

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

Business Wire

24 days ago

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

Vertex to Announce Second Quarter 2024 Financial Results on August 1

Business Wire

25 days ago

Vertex to Announce Second Quarter 2024 Financial Results on August 1

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Motley Fool

25 days ago

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

GuruFocus.com

a month ago

Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares

2 Superior Growth Stocks to Buy if You Have $1,000 Right Now

Motley Fool

a month ago

2 Superior Growth Stocks to Buy if You Have $1,000 Right Now

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool

a month ago

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

2 Healthcare Stocks That Are Screaming Buys in June

Motley Fool

a month ago

2 Healthcare Stocks That Are Screaming Buys in June

Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?

Zacks

a month ago

Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."

Motley Fool

a month ago

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."

MT Newswires

a month ago

Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

MT Newswires

a month ago

Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating

Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

Motley Fool

a month ago

Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong Financial Performance in Q1

Insider Monkey

a month ago

Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong Financial Performance in Q1

Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock

Zacks

a month ago

Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock

Argus Research

a month ago

Technical Assessment: Bullish in the Intermediate-Term

Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial

Clinical Trials Arena

a month ago

Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $555 From $540

MT Newswires

a month ago

Vertex Pharmaceuticals Discloses 'Positive' Data From Phase 1/2 Trial of VX-880 to Treat Type 1 Diabetes

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions

Business Wire

a month ago

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions

Reshma Kewalramani Is Guiding Vertex Pharmaceuticals to Its Next Big Thing

Barrons.com

a month ago

Reshma Kewalramani Is Guiding Vertex Pharmaceuticals to Its Next Big Thing

Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead

Motley Fool

a month ago

Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead

MT Newswires

a month ago

Market Chatter: Vertex Pharmaceuticals Has Pricing Accord for Cystic Fibrosis Drugs With UK National Health Service

Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?

Insider Monkey

a month ago

Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation

Motley Fool

a month ago

3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation

MT Newswires

a month ago

Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465

Argus Research

a month ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

a month ago

Market Digest: COR, DVN, HRL, VRTX, PLTR

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Motley Fool

a month ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?

Insider Monkey

a month ago

Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?

Vertex says Casgevy benefit extends to nearly five years in sickle cell disease

Clinical Trials Arena

a month ago

Vertex says Casgevy benefit extends to nearly five years in sickle cell disease

MT Newswires

a month ago

Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress

Business Wire

a month ago

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress

Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

GuruFocus.com

a month ago

Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,089,840, According to a Recent SEC Filing

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $3,483,664, According to a Recent SEC Filing

Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

a month ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Argus Research

a month ago

May Stock Recovery as Economy Sends Mixed Signals

2 Healthcare Stocks to Buy Hand Over Fist in June

Motley Fool

a month ago

2 Healthcare Stocks to Buy Hand Over Fist in June

MT Newswires

2 months ago

RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424

MT Newswires

2 months ago

Clearwater Analytics Holdings Insider Sold Shares Worth $2,375,416, According to a Recent SEC Filing

Fed will signal September cuts in July meeting: Strategist

Yahoo Finance Video

2 months ago

Fed will signal September cuts in July meeting: Strategist

MT Newswires

2 months ago

Market Chatter: Apollo, Kyndryl May Make Joint Bid for DXC Technology

OnEquity Expands Global Investor Support with Multilingual Services

GlobeNewswire

2 months ago

OnEquity Expands Global Investor Support with Multilingual Services

MT Newswires

2 months ago

Jfrog Insider Sold Shares Worth $485,250, According to a Recent SEC Filing

MT Newswires

2 months ago

Clearwater Analytics Holdings Insider Sold Shares Worth $848,536, According to a Recent SEC Filing

ACCESSWIRE

2 months ago

Jolt Health Inc. Terminates Acquisition Agreement and Shifts Focus to AI Opportunities

Advantage Announces Strategic Asset Acquisition and Concurrent Financing

CNW Group

2 months ago

Advantage Announces Strategic Asset Acquisition and Concurrent Financing

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

Motley Fool

2 months ago

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

Share on Social Networks: